Dynamics of the skeletal muscle secretome during myoblast differentiation

Molecular and Cellular Proteomics

Volumn 9, Issue 11, 2010, Pages 2482-2496

  Henningsen, Jeanette ^a,b   Rigbolt, Kristoffer T G ^a   Blagoev, Blagoy ^a   Pedersen, Bente Klarlund ^b   Kratchmarova, Irina ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; GROWTH FACTOR; HYDROXYPROLINE; MESSENGER RNA; METALLOPROTEINASE; SEMAPHORIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; ISOTOPE LABELING; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEOMICS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; ISOTOPE LABELING; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOBLASTS; PROTEIN ISOFORMS; PROTEOMICS; SEMAPHORINS;

MURINAE;

EID: 78149306422     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.002113     Document Type: Article

References (78)

1. Pedersen, B. K. (2009) The diseasome of physical inactivity - and the role of myokines in muscle-fat cross talk. J. Physiol. 587, 5559-5568
2. Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., and Klarlund Pedersen, B. (2000) Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529, 237-242
3. Pedersen, B. K., and Febbraio, M. A. (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88, 1379-1406
4. Hojman, P., Pedersen, M., Nielsen, A. R., Krogh-Madsen, R., Yfanti, C., Akerstrom, T., Nielsen, S., and Pedersen, B. K. (2009) Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58, 2797-2801
5. Walsh, K. (2009) Adipokines, myokines and cardiovascular disease. Circ. J. 73, 13-18
6. Chan, X. C., McDermott, J. C., and Siu, K. W. (2007) Identification of secreted proteins during skeletal muscle development. J. Proteome Res. 6, 698-710
7. Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., and Houmard, J. A. (2009) Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58, 30-38
8. Yoon, J. H., Yea, K., Kim, J., Choi, Y. S., Park, S., Lee, H., Lee, C. S., Suh, P. G., and Ryu, S. H. (2009) Comparative proteomic analysis of the insulin-induced L6 myotube secretome. Proteomics 9, 51-60
9. Dengjel, J., Kratchmarova, I., and Blagoev, B. (2009) Receptor tyrosine kinase signaling: a view from quantitative proteomics. Mol. Biosyst. 5, 1112-1121
10. Kratchmarova, I., Blagoev, B., Haack-Sorensen, M., Kassem, M., and Mann, M. (2005) Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308, 1472-1477
11. Krüger, M., Kratchmarova, I., Blagoev, B., Tseng, Y. H., Kahn, C. R., and Mann, M. (2008) Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. U.S.A. 105, 2451-2456
12. Prokhorova, T. A., Rigbolt, K. T., Johansen, P. T., Henningsen, J., Kratchmarova, I., Kassem, M., and Blagoev, B. (2009) Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol. Cell. Proteomics 8, 959-970
13. Blagoev, B., and Mann, M. (2006) Quantitative proteomics to study mitogen-activated protein kinases. Methods 40, 243-250 (Pubitemid 44635297)
14. Shevchenko, A., Tomas, H., Havlis, J., Olsen, J. V., and Mann, M. (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856-2860
15. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micropurification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906
16. Olsen, J. V., de Godoy, L. M., Li, G., Macek, B., Mortensen, P., Pesch, R., Makarov, A., Lange, O., Horning, S., and Mann, M. (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4, 2010-2021
17. Cox, J., Matic, I., Hilger, M., Nagaraj, N., Selbach, M., Olsen, J. V., and Mann, M. (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4, 698-705
18. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29
19. Kumar, L., and Futschik, M. E. (2007) Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2, 5-7
20. R Development Core Team (2007) R: a Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria
21. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., and Mann, M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648
22. Crooks, G. E., Hon, G., Chandonia, J. M., and Brenner, S. E. (2004) WebLogo: a sequence logo generator. Genome Res. 14, 1188-1190
23. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
24. Chargé, S. B., and Rudnicki, M. A. (2004) Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238
25. Jansen, K. M., and Pavlath, G. K. (2008) Molecular control of mammalian myoblast fusion. Methods Mol. Biol. 475, 115-133
26. Berkes, C. A., and Tapscott, S. J. (2005) MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16, 585-595
27. Tapscott, S. J. (2005) The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132, 2685-2695
28. Hawke, T. J., and Garry, D. J. (2001) Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551
29. Kollias, H. D., and McDermott, J. C. (2008) Transforming growth factor-beta and myostatin signaling in skeletal muscle. J. Appl. Physiol. 104, 579-587
30. Massagué, J. (2008) TGFbeta in cancer. Cell 134, 215-230
31. Lafyatis, R., Lechleider, R., Roberts, A. B., and Sporn, M. B. (1991) Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis. Mol. Cell. Biol. 11, 3795-3803
32. Stewart, J. D., Masi, T. L., Cumming, A. E., Molnar, G. M., Wentworth, B. M., Sampath, K., McPherson, J. M., and Yaeger, P. C. (2003) Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-beta2. J. Cell. Physiol. 196, 70-78
33. Schabort, E. J., van der Merwe, M., Loos, B., Moore, F. P., and Niesler, C. U. (2009) TGF-beta's delay skeletal muscle progenitor cell differentiation in an isoform-independent manner. Exp. Cell Res. 315, 373-384
34. Zentella, A., and Massagué, J. (1992) Transforming growth factor beta induces myoblast differentiation in the presence of mitogens. Proc. Natl. Acad. Sci. U.S.A. 89, 5176-5180
35. De Angelis, L., Borghi, S., Melchionna, R., Berghella, L., Baccarani-Contri, M., Parise, F., Ferrari, S., and Cossu, G. (1998) Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc. Natl. Acad. Sci. U.S.A. 95, 12358-12363
36. Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., Ramirez, F., Judge, D. P., Ward, C. W., and Dietz, H. C. (2007) Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210
37. McLennan, I. S., and Koishi, K. (1997) Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles. Dev. Dyn. 208, 278-289
38. Budasz-Swiderska, M., Jank, M., and Motyl, T. (2005) Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts. J. Physiol. Pharmacol. 56, Suppl. 3, 195-214
39. Smith, C. A., Stauber, F., Waters, C., Alway, S. E., and Stauber, W. T. (2007) Transforming growth factor-beta following skeletal muscle strain injury in rats. J. Appl. Physiol. 102, 755-761
40. Droguett, R., Cabello-Verrugio, C., Riquelme, C., and Brandan, E. (2006) Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol. 25, 332-341
41. Brandan, E., Cabello-Verrugio, C., and Vial, C. (2008) Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol. 27, 700-708
42. Stewart, C. E., and Rotwein, P. (1996) Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271, 11330-11338
43. Mourkioti, F., and Rosenthal, N. (2005) IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol. 26, 535-542
44. Palsgaard, J., Brown, A. E., Jensen, M., Borup, R., Walker, M., and De Meyts, P. (2009) Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes. Growth Horm. IGF Res. 19, 168-178
45. Rajpathak, S. N., Gunter, M. J., Wylie-Rosett, J., Ho, G. Y., Kaplan, R. C., Muzumdar, R., Rohan, T. E., and Strickler, H. D. (2009) The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab. Res. Rev. 25, 3-12
46. Bach, L. A., Headey, S. J., and Norton, R. S. (2005) IGF-binding proteins-the pieces are falling into place. Trends Endocrinol. Metab. 16, 228-234
47. Duan, C., and Xu, Q. (2005) Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen. Comp. Endocrinol. 142, 44-52
48. Kumar, A., Mohan, S., Newton, J., Rehage, M., Tran, K., Baylink, D. J., and Qin, X. (2005) Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J. Biol. Chem. 280, 37782-37789
49. James, P. L., Jones, S. B., Busby, W. H., Jr., Clemmons, D. R., and Rotwein, P. (1993) A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J. Biol. Chem. 268, 22305-22312
50. Salih, D. A., Tripathi, G., Holding, C., Szestak, T. A., Gonzalez, M. I., Carter, E. J., Cobb, L. J., Eisemann, J. E., and Pell, J. M. (2004) Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. U.S.A. 101, 4314-4319
51. Mukherjee, A., Wilson, E. M., and Rotwein, P. (2008) Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol. Endocrinol. 22, 206-215
52. Ren, H., Yin, P., and Duan, C. (2008) IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop. J. Cell Biol. 182, 979-991
53. Bonaldi, T., Straub, T., Cox, J., Kumar, C., Becker, P. B., and Mann, M. (2008) Combined use of RNAi and quantitative proteomics to study gene function in Drosophila. Mol. Cell 31, 762-772
54. de Godoy, L. M., Olsen, J. V., Cox, J., Nielsen, M. L., Hubner, N. C., Fröhlich, F., Walther, T. C., and Mann, M. (2008) Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455, 1251-1254
55. Florini, J. R., Magri, K. A., Ewton, D. Z., James, P. L., Grindstaff, K., and Rotwein, P. S. (1991) "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266, 15917-15923
56. de Wit, J., and Verhaagen, J. (2003) Role of semaphorins in the adult nervous system. Prog. Neurobiol. 71, 249-267
57. Roth, L., Koncina, E., Satkauskas, S., Crémel, G., Aunis, D., and Bagnard, D. (2009) The many faces of semaphorins: from development to pathology. Cell Mol. Life Sci. 66, 649-666
58. Wu, H., Wang, X., Liu, S., Wu, Y., Zhao, T., Chen, X., Zhu, L., Wu, Y., Ding, X., Peng, X., Yuan, J., Wang, X., Fan, W., and Fan, M. (2007) Sema4C participates in myogenic differentiation in vivo and in vitro through the p38 MAPK pathway. Eur. J. Cell Biol. 86, 331-344
59. Tatsumi, R., Sankoda, Y., Anderson, J. E., Sato, Y., Mizunoya, W., Shimizu, N., Suzuki, T., Yamada, M., Rhoads, R. P., Jr., Ikeuchi, Y., and Allen, R. E. (2009) Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation. Am. J. Physiol. Cell Physiol. 297, C238-C252
60. Delorme, G., Saltel, F., Bonnelye, E., Jurdic, P., and Machuca-Gayet, I. (2005) Expression and function of semaphorin 7A in bone cells. Biol. Cell 97, 589-597
61. McLoon, L. K. (2009) A new role for satellite cells: control of reinnervation after muscle injury by semaphorin 3A. Focus on "Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation". Am. J. Physiol. Cell Physiol. 297, C227-C230
62. Zhou, Y., Gunput, R. A., and Pasterkamp, R. J. (2008) Semaphorin signaling: progress made and promises ahead. Trends Biochem. Sci. 33, 161-170
63. Svensson, A., Libelius, R., and Tågerud, S. (2008) Semaphorin 6C expression in innervated and denervated skeletal muscle. J. Mol. Histol. 39, 5-13
64. Adams, R. H., Lohrum, M., Klostermann, A., Betz, H., and Püschel, A. W. (1997) The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 16, 6077-6086
65. Christensen, C., Ambartsumian, N., Gilestro, G., Thomsen, B., Comoglio, P., Tamagnone, L., Guldberg, P., and Lukanidin, E. (2005) Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res. 65, 6167-6177
66. Gonthier, B., Nasarre, C., Roth, L., Perraut, M., Thomasset, N., Roussel, G., Aunis, D., and Bagnard, D. (2007) Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance. Cereb. Cortex 17, 1712-1721
67. Gonthier, B., Koncina, E., Satkauskas, S., Perraut, M., Roussel, G., Aunis, D., Kapfhammer, J. P., and Bagnard, D. (2009) A PKC-dependent recruitment of MMP-2 controls semaphorin-3A growth-promoting effect in cortical dendrites. PloS One 4, e5099
68. Bani, C., Lagrota-Candido, J., Pinheiro, D. F., Leite, P. E., Salimena, M. C., Henriques-Pons, A., and Quirico-Santos, T. (2008) Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice. Muscle Nerve 37, 583-592
69. Nishimura, T., Nakamura, K., Kishioka, Y., Kato-Mori, Y., Wakamatsu, J., and Hattori, A. (2008) Inhibition of matrix metalloproteinases suppresses the migration of skeletal muscle cells. J. Muscle Res. Cell Motil. 29, 37-44
70. Elhabazi, A., Delaire, S., Bensussan, A., Boumsell, L., and Bismuth, G. (2001) Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J. Immunol. 166, 4341-4347
71. Basile, J. R., Holmbeck, K., Bugge, T. H., and Gutkind, J. S. (2007) MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J. Biol. Chem. 282, 6899-6905 (Pubitemid 47100895)
72. Dean, R. A., and Overall, C. M. (2007) Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol. Cell. Proteomics 6, 611-623
73. Kaelin, W. G. (2005) Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74, 115-128
74. Krane, S. M. (2008) The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 35, 703-710
75. Kratchmarova, I., Kalume, D. E., Blagoev, B., Scherer, P. E., Podtelejnikov, A. V., Molina, H., Bickel, P. E., Andersen, J. S., Fernandez, M. M., Bunkenborg, J., Roepstorff, P., Kristiansen, K., Lodish, H. F., Mann, M., and Pandey, A. (2002) A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 1, 213-222
76. Saltiel, A. R. (2001) You are what you secrete. Nat. Med. 7, 887-888
77. Pedersen, B. K. (2009) Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J. Appl. Physiol. 107, 1006-1014
78. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57, 125-133